Angela Valera Turalba, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 13 | 2022 | 1159 | 2.490 |
Why?
|
| Intraocular Pressure | 18 | 2020 | 1270 | 2.010 |
Why?
|
| Filtering Surgery | 5 | 2017 | 35 | 2.000 |
Why?
|
| Glaucoma, Open-Angle | 12 | 2020 | 706 | 1.260 |
Why?
|
| Sclera | 3 | 2018 | 200 | 1.200 |
Why?
|
| Ciliary Body | 3 | 2019 | 173 | 1.170 |
Why?
|
| Ophthalmology | 6 | 2022 | 508 | 1.140 |
Why?
|
| Phacoemulsification | 4 | 2019 | 149 | 1.110 |
Why?
|
| Visual Acuity | 9 | 2020 | 2530 | 1.070 |
Why?
|
| Laser Coagulation | 2 | 2018 | 326 | 1.020 |
Why?
|
| Glaucoma, Angle-Closure | 4 | 2019 | 189 | 0.930 |
Why?
|
| Cataract Extraction | 5 | 2019 | 481 | 0.890 |
Why?
|
| Eye Injuries, Penetrating | 3 | 2014 | 115 | 0.810 |
Why?
|
| Ocular Hypertension | 4 | 2018 | 198 | 0.790 |
Why?
|
| Exfoliation Syndrome | 3 | 2017 | 110 | 0.790 |
Why?
|
| Lens Implantation, Intraocular | 3 | 2015 | 192 | 0.730 |
Why?
|
| Cataract | 4 | 2016 | 834 | 0.710 |
Why?
|
| Uveal Diseases | 1 | 2018 | 45 | 0.650 |
Why?
|
| Muscle Relaxants, Central | 1 | 2018 | 86 | 0.610 |
Why?
|
| Choroid Diseases | 1 | 2018 | 66 | 0.610 |
Why?
|
| Scleritis | 1 | 2018 | 100 | 0.590 |
Why?
|
| Optic Disk | 5 | 2020 | 400 | 0.570 |
Why?
|
| Iridectomy | 1 | 2016 | 49 | 0.560 |
Why?
|
| Aqueous Humor | 1 | 2017 | 161 | 0.560 |
Why?
|
| Eye | 3 | 2013 | 729 | 0.520 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 875 | 0.510 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2017 | 245 | 0.490 |
Why?
|
| Eye Injuries | 3 | 2013 | 245 | 0.460 |
Why?
|
| Lens, Crystalline | 2 | 2014 | 388 | 0.410 |
Why?
|
| Visual Fields | 5 | 2020 | 1047 | 0.400 |
Why?
|
| Visual Field Tests | 3 | 2017 | 383 | 0.380 |
Why?
|
| Optic Nerve Diseases | 3 | 2020 | 327 | 0.370 |
Why?
|
| Lens Subluxation | 1 | 2010 | 20 | 0.360 |
Why?
|
| Refractive Surgical Procedures | 1 | 2010 | 25 | 0.360 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 2046 | 0.340 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2635 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2017 | 1018 | 0.320 |
Why?
|
| Tonometry, Ocular | 4 | 2019 | 237 | 0.310 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 1643 | 0.310 |
Why?
|
| Caffeine | 1 | 2012 | 699 | 0.300 |
Why?
|
| Coffee | 1 | 2012 | 578 | 0.300 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2219 | 0.290 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15295 | 0.290 |
Why?
|
| Nails | 2 | 2018 | 292 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3022 | 0.250 |
Why?
|
| Quality of Life | 2 | 2016 | 12804 | 0.250 |
Why?
|
| Eye Diseases | 2 | 2013 | 669 | 0.240 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 840 | 0.240 |
Why?
|
| Hyphema | 2 | 2014 | 26 | 0.230 |
Why?
|
| Thrombosis | 1 | 2017 | 2968 | 0.230 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 1148 | 0.230 |
Why?
|
| Vision Disorders | 1 | 2010 | 1058 | 0.220 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 2291 | 0.220 |
Why?
|
| Anticoagulants | 1 | 2017 | 4599 | 0.210 |
Why?
|
| Curriculum | 1 | 2015 | 3605 | 0.210 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 1525 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 491 | 0.200 |
Why?
|
| Quinoxalines | 2 | 2014 | 290 | 0.200 |
Why?
|
| Drug Implants | 3 | 2018 | 244 | 0.200 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 514 | 0.200 |
Why?
|
| Heart Rate | 1 | 2012 | 4091 | 0.190 |
Why?
|
| Bruch Membrane | 2 | 2017 | 64 | 0.190 |
Why?
|
| Clinical Competence | 1 | 2015 | 4687 | 0.180 |
Why?
|
| Ophthalmic Solutions | 2 | 2018 | 317 | 0.180 |
Why?
|
| Carotid Arteries | 1 | 2004 | 952 | 0.180 |
Why?
|
| Glaucoma Drainage Implants | 2 | 2017 | 116 | 0.170 |
Why?
|
| Tomography, Optical Coherence | 4 | 2020 | 2657 | 0.170 |
Why?
|
| Fluocinolone Acetonide | 1 | 2017 | 36 | 0.150 |
Why?
|
| Blood Pressure | 2 | 2018 | 8554 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2004 | 1221 | 0.150 |
Why?
|
| Choroidal Neovascularization | 2 | 2013 | 343 | 0.150 |
Why?
|
| Uveitis, Anterior | 1 | 2017 | 101 | 0.150 |
Why?
|
| Capillaries | 2 | 2018 | 773 | 0.150 |
Why?
|
| Contact Lenses | 1 | 2018 | 145 | 0.150 |
Why?
|
| Humans | 45 | 2022 | 744343 | 0.140 |
Why?
|
| Pregnadienediols | 2 | 2013 | 9 | 0.130 |
Why?
|
| Iris | 1 | 2016 | 239 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2017 | 319 | 0.130 |
Why?
|
| Corneal Diseases | 1 | 2022 | 636 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2015 | 5788 | 0.130 |
Why?
|
| Trabeculectomy | 1 | 2017 | 160 | 0.130 |
Why?
|
| Triamcinolone Acetonide | 2 | 2013 | 101 | 0.120 |
Why?
|
| Low Tension Glaucoma | 1 | 2014 | 22 | 0.120 |
Why?
|
| Photography | 1 | 2017 | 520 | 0.120 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 57776 | 0.120 |
Why?
|
| Aged | 18 | 2020 | 163280 | 0.120 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2013 | 21 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 326 | 0.110 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2014 | 87 | 0.110 |
Why?
|
| Attitude | 1 | 2018 | 776 | 0.110 |
Why?
|
| Timolol | 1 | 2013 | 52 | 0.110 |
Why?
|
| Male | 23 | 2020 | 350118 | 0.110 |
Why?
|
| Basketball | 1 | 2013 | 49 | 0.110 |
Why?
|
| Macular Degeneration | 2 | 2013 | 980 | 0.110 |
Why?
|
| Skin Abnormalities | 1 | 2013 | 60 | 0.110 |
Why?
|
| Homeostasis | 2 | 2014 | 3340 | 0.110 |
Why?
|
| Laser Therapy | 1 | 2019 | 1072 | 0.100 |
Why?
|
| Microcirculation | 1 | 2017 | 1286 | 0.100 |
Why?
|
| Gonioscopy | 1 | 2012 | 157 | 0.100 |
Why?
|
| Vision, Ocular | 1 | 2015 | 464 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2017 | 770 | 0.100 |
Why?
|
| Retinal Perforations | 1 | 2013 | 131 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2004 | 3057 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2013 | 2038 | 0.090 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 2029 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2022 | 77449 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1060 | 0.090 |
Why?
|
| Eye Foreign Bodies | 1 | 2010 | 55 | 0.090 |
Why?
|
| Blast Injuries | 1 | 2013 | 302 | 0.090 |
Why?
|
| Endoscopy | 1 | 2019 | 1785 | 0.080 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.080 |
Why?
|
| Retinal Vessels | 1 | 2014 | 772 | 0.080 |
Why?
|
| Middle Aged | 16 | 2020 | 213383 | 0.080 |
Why?
|
| Enophthalmos | 1 | 2008 | 34 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2015 | 1210 | 0.080 |
Why?
|
| Thiophenes | 1 | 2013 | 588 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1198 | 0.080 |
Why?
|
| Microscopic Angioscopy | 2 | 2018 | 22 | 0.080 |
Why?
|
| Female | 19 | 2020 | 380194 | 0.080 |
Why?
|
| Teaching | 1 | 2015 | 1174 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5708 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2020 | 21746 | 0.070 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2008 | 116 | 0.070 |
Why?
|
| Orbital Fractures | 1 | 2008 | 110 | 0.070 |
Why?
|
| Prospective Studies | 7 | 2017 | 53288 | 0.070 |
Why?
|
| Maxillary Sinus | 1 | 2008 | 180 | 0.070 |
Why?
|
| Beverages | 1 | 2012 | 820 | 0.070 |
Why?
|
| United States | 6 | 2021 | 69872 | 0.070 |
Why?
|
| Maxilla | 1 | 2008 | 470 | 0.060 |
Why?
|
| Vision, Low | 1 | 2007 | 168 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2019 | 63114 | 0.060 |
Why?
|
| Adult | 12 | 2018 | 214055 | 0.060 |
Why?
|
| Young Adult | 4 | 2018 | 56430 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2009 | 764 | 0.060 |
Why?
|
| Eye Proteins | 1 | 2008 | 646 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2013 | 1938 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12959 | 0.050 |
Why?
|
| Haloperidol | 1 | 2004 | 397 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2421 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 1364 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 25043 | 0.050 |
Why?
|
| Veterans | 1 | 2015 | 2519 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2004 | 366 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4234 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2015 | 7729 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2004 | 1472 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2008 | 2263 | 0.040 |
Why?
|
| Lasers | 1 | 2022 | 952 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12026 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2004 | 1101 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2007 | 1859 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1442 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2022 | 642 | 0.040 |
Why?
|
| Prognosis | 2 | 2017 | 29063 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18370 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 2017 | 245 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2004 | 3002 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39050 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6459 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 1387 | 0.030 |
Why?
|
| Public Health | 1 | 2007 | 2603 | 0.030 |
Why?
|
| Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2017 | 687 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13284 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 2014 | 185 | 0.030 |
Why?
|
| Cloprostenol | 1 | 2013 | 22 | 0.030 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1099 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2014 | 311 | 0.030 |
Why?
|
| Sunlight | 1 | 2014 | 325 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2004 | 8436 | 0.030 |
Why?
|
| Explosions | 1 | 2013 | 109 | 0.030 |
Why?
|
| Forecasting | 1 | 2021 | 2951 | 0.030 |
Why?
|
| Occupations | 1 | 2014 | 517 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 549 | 0.030 |
Why?
|
| Israel | 1 | 2014 | 796 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.020 |
Why?
|
| Eyelids | 1 | 2013 | 265 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2017 | 2110 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2022 | 3743 | 0.020 |
Why?
|
| Eye Enucleation | 1 | 2010 | 128 | 0.020 |
Why?
|
| Amides | 1 | 2013 | 459 | 0.020 |
Why?
|
| Risk Factors | 2 | 2014 | 72290 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
| Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 391 | 0.020 |
Why?
|
| Posture | 1 | 2014 | 958 | 0.020 |
Why?
|
| Nasal Bone | 1 | 2008 | 58 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2013 | 1959 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
| Rhode Island | 1 | 2007 | 347 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 2013 | 807 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 794 | 0.020 |
Why?
|
| Orbit | 1 | 2008 | 426 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2010 | 2297 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2014 | 2050 | 0.020 |
Why?
|
| Stents | 1 | 2017 | 3280 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 2902 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 9959 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 29786 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9146 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Syndrome | 1 | 2008 | 3251 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 23403 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12245 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8663 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2002 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 81183 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 2400 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 85781 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 168757 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 41006 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 40075 | 0.000 |
Why?
|
| Child | 1 | 2013 | 77709 | 0.000 |
Why?
|